top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Drugs / Niamh M. O'Boyle, Mary J. Meegan
Anticancer Drugs / Niamh M. O'Boyle, Mary J. Meegan
Autore O'Boyle Niamh M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (214 p.)
Soggetto topico Chemistry
Soggetto non controllato graphene oxide
indole
androgens
cyclooxygenase-2
cyclooxygenase-1
heteropolysaccharide
drug conjugation
drug delivery
ellipticine
chemical linker
oesophageal cancer
antiproliferative activity
topoisomerase II
?-lactam
DSD
antibody
topoisomerase inhibitors
magnetic targeting
cisplatin resistance
steroidogenesis
[18F]FDG PET/CT
heterocyclic chemistry
dehydroepiandrosterone
antimitotic
3-vinylazetidin-2-ones
glioblastoma
and cancer therapy
intestinal mucositis
Combretastatin A-4
metabolism
anti-cancer drugs
maghemite
COX-1 inhibitor
anticancer
CYP17A1
conjugate and hybrid drugs
inflammation
snticancer drugs
P450c17
tumorigenesis
cisplatin
biomarker profiling
cancer drug design
tubulin
cytochrome P450
5-fluorouracil
prostate cancer
abiraterone
NCI screen
radiation
cancer immunotherapy
microtubule targeted drugs
cancer
treatment resistance
ISBN 9783039215874
3039215876
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367753903321
O'Boyle Niamh M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (594 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 1,2,3-triazole
1,3,4-oxadiazole
3-amino-4'-guanidino
3,4'-bis-guanidino
5-fluoruracil
7-deaza-4'-thioadenosine derivatives
acetamide
adamantane
ADC (antibody-drug conjugate)
age
alkylated
anticancer
anticancer activity
anticancer agents
apoptosis
apoptosis induction
aromatase inhibitor
Bcl-2 inhibitors
benzenesulfonamides
benzimidazole
BRAF
breast cancer
cancer
cancer cell viability
cancer vaccine
CAR (chimeric antigen receptor)
cardiotoxicity
carvedilol
cell cycle analysis
chalcone
chalcones
colony formation
combretastatin A-4
concentration-guided dosing
covalent binding
CovDock
cumulative dose
cyclophosphamide
cytotoxic activity
cytotoxic agents
cytotoxicity
designed multiple ligand
diphenyl ether
DNA fragmentation
docking
doxazosin
drug efflux
dual inhibitors
dual-targeting molecule
EGFR
ELISA
enantioselective synthesis
entrectinib
exportin-1
gastric adenocarcinoma
generic product
H1299
HDAC inhibitors
HER2
heterocyclic compound
histopathology
HL-60
HT-29 cells
hybrid compounds
hybrid molecule
hydrazide derivatives
imidazoles
Imiquimod
immunotherapy
in vitro
in vivo
indazole
Indole-based analogues
inflammation
interleukin-6
intramolecular hydrogen bond
isolation
kidney
larotrectinib
letrozole
MD simulations
MDA-MB-231 cells
mechanism prediction
miR-21
mitoxantrone
model informed dosing
MTT cytotoxic assay
MUC1
MUC16
mucin
multi-kinase inhibitor
multidrug resistance
n/a
NaMSA
nitrogen scaffolds
NTRK
nucleoside
oxidative stress
patent review
pemetrexed
phenstatin
phenyl pyridyl ether
physiologically based pharmacokinetics
protein kinase inhibitors
resin acid
solid/lipid nanoparticles
sorafenib
STAT inhibitors
synthesis
TDP1
testis
thieno[2,3-d][1,2,3]triazine
thiourea
thymidylate synthase
tissue-agnostic
Toll-Like Receptor
toxicity
Trk
Trk fusion
trypan blue assay
tryptophanol
tubulin polymerisation inhibitor
tumor spheroids
tyrosil-DNA-phosphodiesterase 1
urinary bladder
USFDA
xanthone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui